Kyle Kathryn W
SEC CIK 2103996 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| LH | Labcorp | EVP, CLO | 3,904 | — | $227.4K | 10 | 2026-02-06 | 2026-07-02 |
Most active insiders at LH, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Schechter Adam H | Pres, CEO, Dir | — | $8.44M |
| 2 | Parham Richelle P | Dir | — | $1.78M |
| 3 | Wilkinson Peter J | SVP, CAO | — | $1.06M |
| 4 | ANDERSON KERRII B | Dir | — | $954.1K |
| 5 | Caveney Brian J | EVP, CMO, CSO, Pres of ED | — | $429.5K |
| 6 | Meltzer Jonathan C | EVP, Ops | — | $298.8K |
| 7 | Summy Amy B. | EVP, CMO | — | $283.4K |
| 8 | Kyle Kathryn W | EVP, CLO | — | $227.4K |
| 9 | van der Vaart Sandra D | EVP, Corp. Affairs | — | $156.0K |
| 10 | Vaughn Bryan T | EVP, Pres, Diagnostics | — | $67.0K |
Transactions 10
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-07-06 09:37 | 2026-07-01 | LH | Labcorp | Kyle Kathryn W | EVP, CLO | M - OptEx | — | +256 | 4,069 | +7% | — |
| DT | 2026-07-06 09:37 | 2026-07-01 | LH | Labcorp | Kyle Kathryn W | EVP, CLO | F - Tax | $283.88 | -73 | 3,996 | -2% | -$20.7K |
| DT | 2026-07-06 09:37 | 2026-07-02 | LH | Labcorp | Kyle Kathryn W | EVP, CLO | S - Sale+OE | $286.19 | -92 | 3,904 | -2% | -$26.3K |
| T | 2026-06-10 09:01 | 2026-06-08 | LH | Labcorp | Kyle Kathryn W | EVP, CLO | S - Sale | $263.89 | -762 | 3,813 | -17% | -$201.1K |
| 2026-03-30 | 2026-03-26 | LH | Labcorp | Kyle Kathryn W | EVP, CLO | A - Grant | $0.00 | +1,584 | 5,026 | +46% | $0 | |
| 2026-03-30 | 2026-03-26 | LH | Labcorp | Kyle Kathryn W | EVP, CLO | F - Tax | $268.38 | -451 | 4,575 | -9% | -$121.0K | |
| D | 2026-02-13 | 2026-02-11 | LH | Labcorp | Kyle Kathryn W | EVP, CLO | M - OptEx | — | +216 | 3,504 | +7% | — |
| D | 2026-02-13 | 2026-02-11 | LH | Labcorp | Kyle Kathryn W | EVP, CLO | F - Tax | $289.89 | -62 | 3,442 | -2% | -$18.0K |
| DM | 2026-02-10 | 2026-02-06+ | LH | Labcorp | Kyle Kathryn W | EVP, CLO | M - OptEx | — | +358 | 3,349 | +12% | — |
| DM | 2026-02-10 | 2026-02-06+ | LH | Labcorp | Kyle Kathryn W | EVP, CLO | F - Tax | $275.60 | -122 | 3,171 | -4% | -$33.6K |
Purchase Sale Sale after option exercise All abbreviations